Related references
Note: Only part of the references are listed.Circadian rhythms: influence on physiology, pharmacology, and therapeutic interventions
Vivaswath S. Ayyar et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2021)
Molecular mechanisms and physiological importance of circadian rhythms
Alina Patke et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
Circadian Clock-Controlled Drug Metabolism: Implications for Chronotherapeutics
Danyi Lu et al.
DRUG METABOLISM AND DISPOSITION (2020)
Identification of rhythmic human CYPs and their circadian regulators using synchronized hepatoma cells
Min Chen et al.
XENOBIOTICA (2020)
The nuclear receptor Rev-erbα participates in circadian regulation of Ugt2b enzymes in mice
Tianpeng Zhang et al.
BIOCHEMICAL PHARMACOLOGY (2019)
Role of the CLOCK protein in liver detoxification
Mengjing Zhao et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
The Molecular Mechanism Regulating Diurnal Rhythm of Flavin-Containing Monooxygenase 5 in Mouse Liver
Min Chen et al.
DRUG METABOLISM AND DISPOSITION (2019)
The Circadian Clock Gene Bmal1 Controls Intestinal Exporter MRP2 and Drug Disposition
Fangjun Yu et al.
THERANOSTICS (2019)
E4bp4 regulates carboxylesterase 2 enzymes through repression of the nuclear receptor Rev-erbα in mice
Mengjing Zhao et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Cytochrome P450 Structure, Function and Clinical Significance: A Review
Palrasu Manikandan et al.
CURRENT DRUG TARGETS (2018)
In Vivo Assessment of the Effect of CYP1A2 Inhibition and Induction on Pomalidomide Pharmacokinetics in Healthy Subjects
Yan Li et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Population pharmacokinetics of theophylline in adult Chinese patients with asthma and chronic obstructive pulmonary disease
Yanjiao Ma et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY (2018)
The Clock Protein Bmal1 Regulates Circadian Expression and Activity of Sulfotransferase 1a1 in Mice
Lianxia Guo et al.
DRUG METABOLISM AND DISPOSITION (2018)
REV-ERBα Regulates CYP7A1 Through Repression of Liver Receptor Homolog-1
Tianpeng Zhang et al.
DRUG METABOLISM AND DISPOSITION (2018)
Small Heterodimer Partner Regulates Circadian Cytochromes p450 and Drug-Induced Hepatotoxicity
Tianpeng Zhang et al.
THERANOSTICS (2018)
Genetic polymorphisms of cytochrome P450-1A2 (CYP1A2) among Emiratis
Mohammad M. Al-Ahmad et al.
PLOS ONE (2017)
Mass spectrometry-based absolute quantification reveals rhythmic variation of mouse circadian clock proteins
Ryohei Narumi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
NPAS2 Compensates for Loss of CLOCK in Peripheral Circadian Oscillators
Dominic Landgraf et al.
PLOS GENETICS (2016)
Direct Regulation of Diurnal Drd3 Expression and Cocaine Reward by NPAS2
Angela R. Ozburn et al.
BIOLOGICAL PSYCHIATRY (2015)
Survey of Human Oxidoreductases and Cytochrome P450 Enzymes Involved in the Metabolism of Xenobiotic and Natural Chemicals
Slobodan Rendic et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2015)
Molecular architecture of the mammalian circadian clock
Carrie L. Partch et al.
TRENDS IN CELL BIOLOGY (2014)
Dysregulation of Npas2 leads to altered metabolic pathways in a murine knockout model
Derek O'Neil et al.
MOLECULAR GENETICS AND METABOLISM (2013)
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
Ulrich M. Zanger et al.
PHARMACOLOGY & THERAPEUTICS (2013)
Constitutive androstane receptor transcriptionally activates human CYP1A1 and CYP1A2 genes through a common regulatory element in the 5′-flanking region
Kouichi Yoshinari et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2
Shu-Feng Zhou et al.
DRUG METABOLISM REVIEWS (2010)
Insights into the Substrate Specificity, Inhibitors, Regulation, and Polymorphisms and the Clinical Impact of Human Cytochrome P450 1A2
Shu-Feng Zhou et al.
AAPS JOURNAL (2009)
Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development
B. Wang et al.
CURRENT MEDICINAL CHEMISTRY (2009)
Polymorphism of human cytochrome P450 enzymes and its clinical impact
Shu-Feng Zhou et al.
DRUG METABOLISM REVIEWS (2009)
Sex Differences in the Expression of Hepatic Drug Metabolizing Enzymes
David J. Waxman et al.
MOLECULAR PHARMACOLOGY (2009)
Interaction of circadian clock proteins PER2 and CRY with BMAL1 and CLOCK
Sonja Langmesser et al.
BMC MOLECULAR BIOLOGY (2008)
The influence of circadian rhythms on the kinetics of drugs in humans
Massimo Baraldo
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2008)
Oscillating perceptions: the ups and downs of the CLOCK protein in the mouse circadian system
Jason P. Debruyne
JOURNAL OF GENETICS (2008)
Evidence for an overlapping role of CLOCK and NPAS2 transcription factors in liver circadian oscillators
Cristiano Bertolucci et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Variation in CYP1A2 activity and its clinical implications: influence of environmental factors and genetic polymorphisms
Arzu Gunes et al.
PHARMACOGENOMICS (2008)
CLOCK and NPAS2 have overlapping roles in the suprachiasmatic circadian clock
Jason P. DeBruyne et al.
NATURE NEUROSCIENCE (2007)
Circadian rhythms: Mechanisms and therapeutic implications
Francis Levi et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2007)
Transcriptional oscillation of canonical clock genes in mouse peripheral tissues
T Yamamoto et al.
BMC MOLECULAR BIOLOGY (2004)
Oscillatory expression of Hes1, p53, and NF-κB driven by transcriptional time delays
NAM Monk
CURRENT BIOLOGY (2003)
Antagonistic role of E4BP4 and PAR proteins in the circadian oscillatory mechanism
S Mitsui et al.
GENES & DEVELOPMENT (2001)
Phenotypic polymorphism and gender-related differences of CYP1A2 activity in a Chinese population
DS Ou-Yang et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2000)
Share Paper
